This law amends the Controlled Substances Act to treat broad classes of chemicals that are structurally related to fentanyl as Schedule I substances unless specifically exempted or placed in another schedule. It defines "fentanyl-related substance" by several chemical changes to the fentanyl molecule and allows the Attorney General to publish a list of such substances in the Federal Register. The law also updates criminal and import/export penalty provisions to include these fentanyl-related substances.
The law creates special, faster registration and administrative procedures for researchers working with Schedule I substances when the research is linked to an investigational new drug application or to research conducted or funded by HHS, the Department of Defense, or the Department of Veterans Affairs. Key researcher provisions include: a 30-day notice process for practitioners already registered for Schedule I or II research; a process where a notice can serve as an application and the Attorney General must act within 45 days for practitioners without prior Schedule I or II research registration; electronic submission; limits on possession tied to notified amounts; and a requirement that an applicant may continue existing research on a substance newly added to Schedule I while a registration application is pending (with a 90-day filing deadline).
The law lets agents or employees at research institutions work under a registered researcher's registration if the registered researcher notifies and authorizes them and the Attorney General does not refuse within 30 days. A single registration can cover multiple research sites within the same city or county under the same institution, if the researcher notifies the Attorney General. Certain small-scale manufacturing activities that are part of research (like making extracts or dosage form development) are allowed without a separate manufacturing registration if stated in the notification or protocol. The Attorney General must issue rules to implement the law within 6 months and may use interim final rules. The Department of Justice Inspector General must complete a study on specified fentanyl research within 1 year of enactment.
Researchers: If you work on investigational drugs or on projects funded or run by HHS, DOD, or VA, you may use the expedited notice-based registration process. Existing Schedule I/II registrants can start certain research 30 days after sending a notice; new registrants may receive a registration or an order to show cause within 45 days. You may possess only the amounts listed in your notice unless you send a supplemental notice. If a substance is newly scheduled, you may continue approved research while you apply within 90 days.
Research institutions and staff: Agents or employees may be authorized to work under a registered researcher’s registration if the researcher notifies and authorizes them and the Attorney General does not refuse within 30 days. Multiple local sites under the same institution can be covered by a single registration after notification.
Manufacturers and labs doing research manufacturing: Small-scale manufacturing tied directly to research or dosage-form development may not require a separate manufacturing registration if included in the notification or protocol. Growing marijuana remains excluded from that authority.
Law enforcement, importers, and the public: A broad set of fentanyl-related chemicals are now treated as Schedule I unless exempted, and penalties and import/export provisions referencing fentanyl analogues are expanded to include fentanyl-related substances.
No publicly available information on budgetary cost estimates or fiscal impact is included in the text. The law does require administrative actions (rulemaking by the Attorney General within 6 months and an Inspector General study within 1 year), but the text does not provide cost figures.
No publicly available information in the provided text describing proponents' stated arguments or detailed rationale beyond the text of the law itself.
No publicly available information in the provided text describing opponents' stated arguments or concerns.